Inhibition of APE1 Expression Enhances the Antitumor Activity of Olaparib in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer that is prone to recurrence and metastasis. Because of the lack of expression of estrogen receptor (ER) and progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) in TNBC, treatment methods a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jian, Dan, Li, Xue-Mei, Dai, Nan, Liang, Dan-Dan, Zhang, Gang, Mao, Cheng-Yi, Wang, Dong, Song, Guan-Bin, Li, Meng-Xia, Luo, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020940/
https://www.ncbi.nlm.nih.gov/pubmed/35463096
http://dx.doi.org/10.1155/2022/6048017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020940/
https://www.ncbi.nlm.nih.gov/pubmed/35463096
http://dx.doi.org/10.1155/2022/6048017

Ejemplares similares